Art. 16 Regulation (EU) 2025/117

Personal data processing

In forcesince 24 Jan 2025
1.

The Commission shall be the controller of the processing of personal data collected for the purpose of conducting joint scientific consultations on medical devices and in vitro diagnostic medical devices under this Regulation.

2.

The categories of personal data necessary for the purpose referred to in paragraph 1 are:

(a)

the identity, email address and affiliation of the representatives appointed to the Coordination Group and the JSC Subgroup;

(b)

the identity and email address of individual experts in any of the following cases:

(i)

they are identified as relevant for joint scientific consultation;

(ii)

they are selected to be consulted in a joint scientific consultation;

(iii)

they are consulted in a joint scientific consultation;

(c)

the identity, email address and affiliation of the representatives of health technology developers;

(d)

the identity, email address and affiliation of the representatives of the members of the stakeholder network established pursuant to Article 29 of Regulation (EU) 2021/2282;

(e)

the identity, email address and affiliation of participants involved in the expert panel consultation referred to in Article 8(6), points (b) and (c), and Article 13(2) that are to be invited to the meeting with the health technology developer;

(f)

the identity, email address and affiliation of participants referred to in Article 13(2), third subparagraph, that are to be invited to the meeting with the health technology developer.

3.

The representatives appointed to the Coordination Group and the JSC Subgroup shall have access only to the parts of the secure system of the HTA IT platform that are relevant for the performance of their tasks. Representatives may collaborate, through the HTA IT platform, with other representatives appointed to the Coordination Group, or the JSC Subgroup to which they belong, for the purposes of conducting joint scientific consultations on medical devices and in vitro diagnostic medical devices.

4.

During the meeting referred to in Article 13, patients shall not be obliged to disclose their identity to the health technology developer.

5.

The Commission shall keep the personal data referred to in paragraph 2 only for as long as necessary for the purpose referred to in paragraph 1 and no longer than 15 years after the date on which the data subject no longer participates in joint scientific consultation. The Commission shall review the necessity of storing the personal data every 2 years.

The Commission shall keep the personal data of individual experts not selected to be consulted in a joint scientific consultation only for as long as necessary in order to ensure the relevant in-depth specialised expertise in joint scientific consultation and no longer than 3 years after the date on which the Commission received this data.